Ferentis awarded “Company of the Year”15th May
Ferentis awarded “Company of the Year” at European Lab Automation 2014
Prize delivered by Mikael Kubista, TATAA.
Ferentis is a new research-intensive biotechnology company involved in the development, production and commercialisation of peptides and biomimetic scaffolds for life-sciences and biomedical applications. The company is an exemplary new startup in life sciences – an entity encompassing translational, interdisciplinary and international co-operation. The company was started in Vilnius, Lithuania, by a group of 4 scientists and entrepreneurs from Canada, Lithuania, Sweden and India. It was born as a result of collaborative research of its founders in the development of “smart” biomaterials that can promote regeneration of tissue cells within the patient without any need of long-term immunosuppressive drugs. The group combines a unique combination of skills, state-of-the-art scientific research and experience in the fields of biomaterials’ enhanced cell regeneration, medicinal chemistry, peptidomimetics and surface nano-technology.